How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Survey that was completed by the Senior BioPhorum Connect group, which consists of the leaders and spons...
PUPSIT: identifying risks and preventive controls
Pre-use post-sterilization integrity testing (PUPSIT) continues to generate considerable debate in the industry. Committ...
A clear path to implementing alternative and rapid microbiological methods
Several alternative and rapid microbiological methods (ARMM) are now available to detect and enumerate microbiological c...
How to solve the CCI puzzle
Container–closure integrity (CCI) is a vital patient-safety and product-efficacy aspect of parenteral biopharmaceutica...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
How to learn about PUPSIT in terminal sterilizing filtration – the science, implications and implementation
How to learn about PUPSIT in terminal sterilizing filtration – the science, implications and implementation Pre-use po...
Removing human intervention in aseptic filling: Realizing the full potential of seamless integration of robotics in filling operations
The greatest source of contamination in any clean room are the humans who work there. Historically this has been control...
BioPhorum contributes to the US Congressional drug wastage debate
A BioPhorum Fill Finish team has given its rationale for vial-size choices in the pharmaceutical development process to ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Surv...
PUPSIT: identifying risks and preventive controls
Pre-use post-sterilization integrity testing (PUPSIT) continues to generate considerable debate in the industry. Committ...
A clear path to implementing alternative and rapid microbiological methods
Several alternative and rapid microbiological methods (ARMM) are now available to detect and enumerate microbiological c...
How to solve the CCI puzzle
Container–closure integrity (CCI) is a vital patient-safety and product-efficacy aspect of parenteral biopharmaceutica...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
How to learn about PUPSIT in terminal sterilizing filtration – the science, implications and implementation
How to learn about PUPSIT in terminal sterilizing filtration – the science, implications and implementation Pre-use po...
Removing human intervention in aseptic filling: Realizing the full potential of seamless integration of robotics in filling operations
The greatest source of contamination in any clean room are the humans who work there. Historically this has been control...
BioPhorum contributes to the US Congressional drug wastage debate
A BioPhorum Fill Finish team has given its rationale for vial-size choices in the pharmaceutical development process to ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
